FDA Inspection 1163854 — H&H Peptides, Inc.
The FDA completed an inspection of H&H Peptides, Inc. on February 17, 2022 in Menlo Park, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 17, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Menlo Park, CA (United States)